Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Letters: Observations

Effect of Sildenafil on Diabetic Gastropathy

  1. Alessandro Bianco, MD1,
  2. Dario Pitocco, MD1,
  3. Venanzio Valenza, MD2,
  4. Salvatore Caputo, MD1,
  5. Ant Grieco, MD1,
  6. Luca Miele, MD1,
  7. Aldo Virgilio Greco, MD1 and
  8. Giovanni Ghirlanda, MD1
  1. 1Medicina Interna, Università Cattolica, Rome, Italy
  2. 2Medicina Nucleare, Università Cattolica, Rome, Italy
    Diabetes Care 2002 Oct; 25(10): 1888-1889. https://doi.org/10.2337/diacare.25.10.1888-a
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Diabetic gastropathy (DG) is the most serious neuromuscular dysfunction of the stomach that may affect diabetic patients. DG is a syndrome of delayed gastric emptying correlated to alterations of gastric tone, contractility, and myoelectrical activity. Gastric dysrhythmias, antral hypomotility, antral dilation, antroduodenal incoordination, and pylorospasm variously relate to DG.

    DG pathogenesis is multifactorial: autonomic neuropathy, microangiopathy, and the degenerative impairment of gastric neuromuscular structure are possible mechanisms of gastric dysfunction. Also, the acute increase in blood glucose might reversibly delay gastric emptying (1,2). Gastric dysrhythmias correlate with a disturbance of gastric electrical slow waves (ESWs). ESW rhythm, which is generated by interstitial cells of Cajal, coordinates gastric peristalsis (3,4). Cajal cells, distributed in specific locations within the enteric tunica muscolaris, serve as electrical pacemakers and mediators of neuromuscolar transmission (5).

    These cells have close relationships with neurons of myenteric plexus and are specifically responsive to nitric oxide (NO) neurotransmission through the activation of their intracellular cyclic guanosin monophosphate (cGMP), the second messenger of the nitrergic pathway (5,6). Injury or reversible impairment of gastric nitrergic neurons or of Cajal cells may alter nerve-muscle communications. In this sense, reduced NO-dependent neurotransmission might be crucial in the loss of coordinated mechanical smooth muscle response in diabetic patients. Sildenafil, a drug that inhibits phosphodiesterase type 5 (PD-5)-mediated cGMP breakdown, might increase cGMP of Cajal cells when the signal linked to NO is low. It is conceivable that in DG, sildenafil could improve gastric emptying by reversing the loss of nitrergic neurotransmission, as already demonstrated in animal models (7).

    We recently observed two patients with DG and evaluated a new therapeutic approach to gastric emptying using sildenafil. Two type 1 diabetic females, aged 45 and 40 years and not pregnant, were hospitalized for acute diabetic gastroparesis with early satiety and postprandial fullness, recurrent nausea, vomiting, and heartburn. A complete laboratory workup evidenced normal complete blood cell count, blood urea nitrogen, creatinine, sodium, and potassium. According to the criteria outlined by Ewing and Clarke, a total score >6 was found as index of autonomic nerve damage (8). A complete gastrointestinal radiographic and endoscopic study ruled out peptic disease or mechanical obstructions. Common prokinetic drugs did not relieve symptoms. After informed consent, both patients were evaluated by gastric scintigraphy to assess a possible therapeutic effect of sildenafil. The gastric emptying scintigraphy was perfomed three times: on the first day, without drugs, to obtain a baseline study and on the second and third days 30 min after the oral administration of two different drugs, sildenafil (50 mg tablets) or placebo (vitamin A), according to a randomization to evaluate the different effects of the drugs on gastric emptying. After an overnight fast, each subject consumed, in 5 min, a solid meal that consisted of a sandwich with two 99mTc MAA-scrambled eggs (74 MBq) and a glass of water (9). The gastric emptying parameters examined were lag phase, which is defined as when activity first exits the stomach (10), half time in minutes, and residual activity at 120 min in percent. The improvement of gastring emptying parameters was only observed after sildenafil administration (Table 1).

    Our data seem to confirm the involvement of nitrergic gastric neurotransmission in DG. It would be interesting to further evaluate PD-5 inhibitors as a new therapeutic approach to diabetic gastroparesis.

    View this table:
    • View inline
    • View popup
    Table 1—

    Gastric emptying scintigraphy data from two patients affected by diabetic gastroparesis before and after sildenafil and placebo administration

    Footnotes

    • Address correspondence to Giovanni Ghirlanda, Servizio di Diabetologia Università, Cattolica del Sacro, Cuore, Largo A. Gemelli 00168, Roma, Italy. E-mail: gghirlanda{at}rm.unicatt.it.

    • DIABETES CARE

    References

    1. ↵
      Rayner CK, Samson M, Jones KL, Horowitz M: Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 24: 371–381, 2001
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Watkins PJ: The enigma of autonomic failure in diabetes. J Roy Phys London 32: 360–365, 1998
    3. ↵
      Thuneberg L: Interstitial cells of Cajal. In Handbook of Physiology. The Gastrointestinal System. Sect. 6, vol. 1. Bethesda, MD, American Physiological Society, 1989, p. 349–386
    4. ↵
      Chen JD, Lin Z, Pan J, McCallun RW: Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci 41: 1538–1545, 1996
      OpenUrlCrossRefPubMedWeb of Science
    5. ↵
      Ward SM: Interstitial cell of Cajal in enteric neurotransmission. Gut 40–43, 2000
    6. ↵
      Sanders KM, Ward SM: Nitric oxide as mediator of nonadrenergic noncholinergic neurotrasmission. Am J Physiol 262: G379–G382,1992
      OpenUrlAbstract/FREE Full Text
    7. ↵
      Watkins CC, Sawa A, Jaffrey S, Blackshaw S, Barrow RK, Snyder SH, Ferris CD: Insulin restores natural nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 106: 373–384, 2000
      OpenUrlPubMedWeb of Science
    8. ↵
      Ewing DJ, Clarke BF: Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285: 916–918, 1982
    9. ↵
      Siegel JA, Wu RK, Knigth LC, Zelac RE, Stern HS, Malmud LS: Radiation dose estimates for oral agents used in upper gastrointestinal disease. J Nucl Med 24: 835–838, 1983
      OpenUrlAbstract/FREE Full Text
    10. ↵
      Chatterton BE: Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh, Churchill Livingstone, Vol. 1. 1994, p. 393–405
    PreviousNext
    Back to top
    Diabetes Care: 25 (10)

    In this Issue

    October 2002, 25(10)
    • Table of Contents
    • About the Cover
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes Care.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Effect of Sildenafil on Diabetic Gastropathy
    (Your Name) has forwarded a page to you from Diabetes Care
    (Your Name) thought you would like to see this page from the Diabetes Care web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Effect of Sildenafil on Diabetic Gastropathy
    Alessandro Bianco, Dario Pitocco, Venanzio Valenza, Salvatore Caputo, Ant Grieco, Luca Miele, Aldo Virgilio Greco, Giovanni Ghirlanda
    Diabetes Care Oct 2002, 25 (10) 1888-1889; DOI: 10.2337/diacare.25.10.1888-a

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Effect of Sildenafil on Diabetic Gastropathy
    Alessandro Bianco, Dario Pitocco, Venanzio Valenza, Salvatore Caputo, Ant Grieco, Luca Miele, Aldo Virgilio Greco, Giovanni Ghirlanda
    Diabetes Care Oct 2002, 25 (10) 1888-1889; DOI: 10.2337/diacare.25.10.1888-a
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Footnotes
      • References
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Weight Gain and Gestational Diabetes Mellitus Is a Sensitive Issue
    • Beneficial Effects of a 4-Week Exercise Program on Plasma Concentrations of Adhesion Molecules
    • Malignant Melanoma Misdiagnosed as a Diabetic Foot Ulcer
    Show more Letters: Observations

    Similar Articles

    Navigate

    • Current Issue
    • Standards of Care Guidelines
    • Online Ahead of Print
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.